J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 78 (1997), 2813-2820
© 1997 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasan, M. K.
Right arrow Articles by Nagai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasan, M. K.
Right arrow Articles by Nagai, Y.
Agricola
Right arrow Articles by Hasan, M. K.
Right arrow Articles by Nagai, Y.

Journal of General Virology, Vol 78, 2813-2820, Copyright © 1997 by Society for General Microbiology


ARTICLES

Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus

MK Hasan, A Kato, T Shioda, Y Sakai, D Yu and Y Nagai
Department of Viral Infection, Institute of Medical Science, University of Tokyo, Japan.

A genetic engineering approach was made to generate a recombinant non- segmented negative-strand RNA virus, Sendai virus (SeV) of the family Paramyxoviridae, that expresses firefly luciferase. The DNA construct containing the entire open reading frame (ORF) of the luciferase gene followed by the SeV transcription stop and restart signals connected with the conserved intergenic three nucleotides was inserted immediately before the ORF of the viral 3'-proximal nucleocapsid (N) protein gene in a full-length SeV cDNA copy. After intracellular expression of full-length antigenomic transcripts from the engineered cDNA and of the viral n ucleocapsid protein and RNA polymerase from the respective plasmids, a recombinant SeV expressing luciferase activity at a high level was recovered, although the tendency of this particular reporter gene product to aggregate in cells made it difficult to estimate the maximum level of expression. The increase in genome length brought about by inserting 1728 nucleotides into the 15,384 nucleotide parental SeV was associated with reduced plaque size, slightly slower replication kinetics and a severalfold decrease in yield of the virus. The inserted luciferase gene was stably maintained after numerous rounds of replication by serial passages in chick embryos. These results indicate the potential utility of SeV as a novel expression vector.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Nishimura, H. Segawa, T. Goto, M. Morishita, A. Masago, H. Takahashi, Y. Ohmiya, T. Sakaguchi, M. Asada, T. Imamura, et al.
Persistent and Stable Gene Expression by a Cytoplasmic RNA Replicon Based on a Noncytopathic Variant Sendai Virus
J. Biol. Chem., September 14, 2007; 282(37): 27383 - 27391.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Takeda, Y. Nakatsu, S. Ohno, F. Seki, M. Tahara, T. Hashiguchi, and Y. Yanagi
Generation of Measles Virus with a Segmented RNA Genome
J. Virol., May 1, 2006; 80(9): 4242 - 4248.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Huang, S. Elankumaran, A. S. Yunus, and S. K. Samal
A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDV
J. Virol., September 15, 2004; 78(18): 10054 - 10063.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Inoue, Y. Tokusumi, H. Ban, T. Kanaya, M. Shirakura, T. Tokusumi, T. Hirata, Y. Nagai, A. Iida, and M. Hasegawa
A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading
J. Virol., June 1, 2003; 77(11): 6419 - 6429.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Inoue, Y. Tokusumi, H. Ban, T. Kanaya, T. Tokusumi, Y. Nagai, A. Iida, and M. Hasegawa
Nontransmissible Virus-Like Particle Formation by F-Deficient Sendai Virus Is Temperature Sensitive and Reduced by Mutations in M and HN Proteins
J. Virol., March 1, 2003; 77(5): 3238 - 3246.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Yamada, N. Kaji, T. Odawara, J. Chiba, A. Iwamoto, and Y. Kitamura
Proline 78 Is Crucial for Human Immunodeficiency Virus Type 1 Nef To Down-Regulate Class I Human Leukocyte Antigen
J. Virol., December 20, 2002; 77(2): 1589 - 1594.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
G. Neumann, M. A. Whitt, and Y. Kawaoka
A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?
J. Gen. Virol., November 1, 2002; 83(11): 2635 - 2662.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Kawana-Tachikawa, M. Tomizawa, J.-i. Nunoya, T. Shioda, A. Kato, E. E. Nakayama, T. Nakamura, Y. Nagai, and A. Iwamoto
An Efficient and Versatile Mammalian Viral Vector System for Major Histocompatibility Complex Class I/Peptide Complexes
J. Virol., October 25, 2002; 76(23): 11982 - 11988.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. W. Wertz, R. Moudy, and L. A. Ball
Adding Genes to the RNA Genome of Vesicular Stomatitis Virus: Positional Effects on Stability of Expression
J. Virol., June 27, 2002; 76(15): 7642 - 7650.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Kato, Y. Ohnishi, M. Hishiyama, M. Kohase, S. Saito, M. Tashiro, and Y. Nagai
The Amino-Terminal Half of Sendai Virus C Protein Is Not Responsible for either Counteracting the Antiviral Action of Interferons or Down-Regulating Viral RNA Synthesis
J. Virol., June 14, 2002; 76(14): 7114 - 7124.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Kano, T. Matano, A. Kato, H. Nakamura, A. Takeda, Y. Suzaki, Y. Ami, K. Terao, and Y. Nagai
Primary replication of a recombinant Sendai virus vector in macaques
J. Gen. Virol., June 1, 2002; 83(6): 1377 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Masaki, Y. Yonemitsu, A. Yamashita, S. Sata, M. Tanii, K. Komori, K. Nakagawa, X. Hou, Y. Nagai, M. Hasegawa, et al.
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia: Acceleration of Limb Loss by Overexpression of Vascular Endothelial Growth Factor 165 but not of Fibroblast Growth Factor-2
Circ. Res., May 17, 2002; 90(9): 966 - 973.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Ito, M. Takayama, K. Yamada, M. Sugiyama, and N. Minamoto
Rescue of Rabies Virus from Cloned cDNA and Identification of the Pathogenicity-Related Gene: Glycoprotein Gene Is Associated with Virulence for Adult Mice
J. Virol., October 1, 2001; 75(19): 9121 - 9128.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
Z. Huang, S. Krishnamurthy, A. Panda, and S. K. Samal
High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus
J. Gen. Virol., July 1, 2001; 82(7): 1729 - 1736.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Shioda, E. E. Nakayama, Y. Tanaka, X. Xin, H. Liu, A. Kawana-Tachikawa, A. Kato, Y. Sakai, Y. Nagai, and A. Iwamoto
Naturally Occurring Deletional Mutation in the C-Terminal Cytoplasmic Tail of CCR5 Affects Surface Trafficking of CCR5
J. Virol., April 1, 2001; 75(7): 3462 - 3468.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. A. Haller, T. Miller, M. Mitiku, and K. Coelingh
Expression of the Surface Glycoproteins of Human Parainfluenza Virus Type 3 by Bovine Parainfluenza Virus Type 3, a Novel Attenuated Virus Vaccine Vector
J. Virol., December 15, 2000; 74(24): 11626 - 11635.
[Abstract] [Full Text]


Home page
J. Virol.Home page
H.-O. Li, Y.-F. Zhu, M. Asakawa, H. Kuma, T. Hirata, Y. Ueda, Y.-S. Lee, M. Fukumura, A. Iida, A. Kato, et al.
A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression
J. Virol., July 15, 2000; 74(14): 6564 - 6569.
[Abstract] [Full Text]


Home page
FASEB J.Home page
T. AKAIKE, S. FUJII, A. KATO, J. YOSHITAKE, Y. MIYAMOTO, T. SAWA, S. OKAMOTO, M. SUGA, M. ASAKAWA, Y. NAGAI, et al.
Viral mutation accelerated by nitric oxide production during infection in vivo
FASEB J, July 1, 2000; 14(10): 1447 - 1454.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. K. Clarke, M. S. Sidhu, J. E. Johnson, and S. A. Udem
Rescue of Mumps Virus from cDNA
J. Virol., May 15, 2000; 74(10): 4831 - 4838.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
E. P. Walsh, M. D. Baron, J. Anderson, and T. Barrett
Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein
J. Gen. Virol., March 1, 2000; 81(3): 709 - 718.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. Kato, K. Kiyotani, M. K. Hasan, T. Shioda, Y. Sakai, T. Yoshida, and Y. Nagai
Sendai Virus Gene Start Signals Are Not Equivalent in Reinitiation Capacity: Moderation at the Fusion Protein Gene
J. Virol., November 1, 1999; 73(11): 9237 - 9246.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. D. Baron, M. Foster-Cuevas, J. Baron, and T. Barrett
Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus
J. Gen. Virol., August 1, 1999; 80(8): 2031 - 2039.
[Abstract] [Full Text]


Home page
J. Virol.Home page
B. P. H. Peeters, O. S. de Leeuw, G. Koch, and A. L. J. Gielkens
Rescue of Newcastle Disease Virus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence
J. Virol., June 1, 1999; 73(6): 5001 - 5009.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Palese
RNA virus vectors: Where are we and where do we need to go?
PNAS, October 27, 1998; 95(22): 12750 - 12752.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Shioda, H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E. E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al.
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha ) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
PNAS, May 26, 1998; 95(11): 6331 - 6336.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Tapparel, D. Maurice, and L. Roux
The Activity of Sendai Virus Genomic and Antigenomic Promoters Requires a Second Element Past the Leader Template Regions: a Motif (GNNNNN)3 Is Essential for Replication
J. Virol., April 1, 1998; 72(4): 3117 - 3128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.